Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefit VCAR33 ALLO demonstrates encouraging biomarker data at lowest dose New asset VADC45 with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback